Zoetis Inc. (NYSE:ZTS) Shares Purchased by Lebenthal Global Advisors LLC

Lebenthal Global Advisors LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 9.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,266 shares of the company’s stock after buying an additional 107 shares during the period. Lebenthal Global Advisors LLC’s holdings in Zoetis were worth $247,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ZTS. Mission Wealth Management LP lifted its position in Zoetis by 33.0% during the first quarter. Mission Wealth Management LP now owns 3,439 shares of the company’s stock valued at $582,000 after buying an additional 853 shares in the last quarter. Prosperity Consulting Group LLC lifted its position in Zoetis by 20.7% during the first quarter. Prosperity Consulting Group LLC now owns 2,073 shares of the company’s stock valued at $351,000 after buying an additional 356 shares in the last quarter. Blue Trust Inc. lifted its position in Zoetis by 15.6% during the first quarter. Blue Trust Inc. now owns 2,687 shares of the company’s stock valued at $455,000 after buying an additional 363 shares in the last quarter. Resonant Capital Advisors LLC raised its stake in shares of Zoetis by 24.3% during the first quarter. Resonant Capital Advisors LLC now owns 1,652 shares of the company’s stock valued at $280,000 after purchasing an additional 323 shares during the period. Finally, PDS Planning Inc raised its stake in shares of Zoetis by 5.4% during the first quarter. PDS Planning Inc now owns 2,200 shares of the company’s stock valued at $372,000 after purchasing an additional 112 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ZTS shares. Piper Sandler lifted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Stifel Nicolaus lifted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. lifted their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, BTIG Research lifted their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average target price of $221.44.

Zoetis Stock Up 1.8 %

Shares of NYSE:ZTS opened at $181.95 on Friday. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The company has a fifty day simple moving average of $188.97 and a 200 day simple moving average of $178.51. The firm has a market cap of $82.43 billion, a PE ratio of 35.61, a price-to-earnings-growth ratio of 2.78 and a beta of 0.90. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same quarter in the previous year, the firm earned $1.41 earnings per share. The business’s revenue was up 8.3% compared to the same quarter last year. On average, equities research analysts anticipate that Zoetis Inc. will post 5.83 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.95%. Zoetis’s payout ratio is 33.66%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.